Methods and compositions for improving cognitive performance

a cognitive performance and composition technology, applied in the field of brain health and cognitive function, can solve the problems of disadvantaged patients with neuropsychological diseases affecting the frontal brain in educational, occupational, social situations, etc., and achieve the effect of improving cognitive performance, increasing speed, accuracy, or effectiveness the performance of a cognitive function

Pending Publication Date: 2010-02-18
THE MCLEAN HOSPITAL CORP
View PDF77 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0006]In preferred embodiments, the improved cognitive performance is increased attention or attentional control, accuracy under time pressure, working memory, or learning aptitude; the compound administered is CDP-choline, uridine, or triacetyl uridine; the cytidine-containing or uridine-containing compound is provided in a nutraceutical composition, e.g., a drink or tablet, optionally containing one or more of vitamin B6, vitamin B12, niacin, folic acid, tyrosine, phenylalanine, taurine, malic acid, glucuronolactone, and caffeine; and the cytidine-containing or uridine-containing compound is administered orally.
[0009]In another aspect, the invention features a nutraceutical composition comprising an effective amount of a cytidine-containing or uridine-containing compound and optionally additional ingredients, e.g., vitamin B6, vitamin B12, niacin, folic acid, tyrosine, phenylalanine, taurine, malic acid, glucuronolactone, and caffeine, for administration to a neuropsychologically healthy human to improve the cognitive function of the human. Desirably, the cytidine-containing or uridine-containing compound is selected from CDP-choline, uridine, and triacetyl uridine.
[0013]By “improving cognitive performance” is meant increasing in speed, accuracy, or effectiveness the performance of a cognitive function. By “cognitive function” is meant mental processes involving manipulation of information and sensory input.
[0020]By “accuracy under time pressure” is meant the ability to complete a mental task without error when a limited amount of time is given to complete the mental task.

Problems solved by technology

Patients with neuropsychological diseases affecting the frontal brain are disadvantaged in educational, occupational, and social situations.
However, because cognitive performance fundamentally limits achievement throughout life, it would be desirable for neuropsychologically health persons to improve cognitive performance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for improving cognitive performance
  • Methods and compositions for improving cognitive performance
  • Methods and compositions for improving cognitive performance

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0055]31P data were collected using a three-dimensional chemical shift imaging (3D-CSI) technique at 4 Tesla in healthy middle-aged individuals. The use of 3D-CSI at high field has several advantages over previous methods: 1) increased spectral dispersion, which allows for increased precision of metabolite quantification; 2) post-processing grid shifting that allows for 3D placement of voxels of interest; and 3) the ability to co-register voxel placement between baseline and post-treatment follow-up. High-energy metabolite peaks quantified in the present study include phosphocreatine (PCr), β-nucleoside triphosphate (NTP, ATP in brain), and inorganic phosphate (Pi). Phospholipid membrane metabolite peaks quantified include anabolites, phosphomonoesters (PME), including phosphoethanolamine (PE) and phosphocholine (PC), and catabolites, phosphodiesters (PDE), including glycerophosphoethanolamine (GPE) and glycerolphosphocholine (GPC). A region of interest approach was used to examine ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
frequencyaaaaaaaaaa
hyperactivity disorderaaaaaaaaaa
Login to view more

Abstract

The invention provides methods and compositions for improving cognitive performance involving administration of a cytidine-containing or uridine-containing compound to a neuropsychologically healthy human.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims benefit of U.S. Provisional Application No. 61 / 089,331, filed Aug. 15, 2008, which is hereby incorporated by reference.BACKGROUND OF THE INVENTION[0002]The invention relates to the fields of brain health and cognitive function.[0003]Cognition encompasses the high level intellectual functions carried out by the brain, including comprehension, speech, visual perception, calculation, attention, memory, problem-solving, and self-monitoring. The frontal brain serves important executive functions in cognition, e.g., the ability to suppress unacceptable social responses. Within the frontal brain, the anterior cingulate cortex (ACC) is thought to encode working memory, detect / evaluate errors, and direct attention appropriately. Patients with neuropsychological diseases affecting the frontal brain are disadvantaged in educational, occupational, and social situations.[0004]Several treatments exist for impaired cognitive func...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/7068A61K31/7072
CPCA23L1/30A23L1/3051A23L1/302A23L1/3012A23L33/10A23L33/13A23L33/15A23L33/175
Inventor RENSHAW, PERRYYURGELUN-TODD, DEBORAH
Owner THE MCLEAN HOSPITAL CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products